Amgen Inc (NASDAQ: AMGN)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $276.39
  • Support level
    N/A
  • Resistance level
    $281.97
  • Beta
    0.4
  • RSI (14-day)
    27.9
  • AMGN is one of this month's worst performers with a return of -4.8 percent, underperforming 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • AMGN is below its 200-day moving average - additional caution warranted in long positions.
  • With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.
  • Price broke below prior support level - a short-term bearish signal.

52-week range

52-week low 52-week high Price as % of range
$258.59 $337.38 25.0%

Moving averages

200 day 50 day 20 day 10 day
$287.91 $292.75 $287.11 $282.00

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    6.4%
  • In the next month
    13.4%
  • In the next year
    52.0%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 23.4%
Last month 23.8%
Current estimate 23.6%
Next month forecast 23.6%